Expanded Portfolio for Biomolecules Purification Announced

Oct 12 2017 Comments 0

With the increased interest in the purification of a wider variety of biomolecules, the portfolio of Kromasil 300 Å has been expanded to support these applications.

The Kromasil 300 Å line of HPLC products is now shipping with C18, C8, C4 and diC4 derivatisations for scientists and engineers exploiting selectivity and loadability for purification of API and impurity isolation. In particular, the new Kromasil 300 Å diC4 has different characteristic than a classic C4, enabling new opportunities to remove impurities from peptide and protein crudes.

For more information, visit

Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Digital Edition

Labmate UK & Ireland October / November 2017

November 2017

In this Issue Articles - How to Achieve Ultimate PCR Optimisation Spotlight Features - Incubators, Freezers & Cooling Equipment - Balances & Strain Gauges - Proteomics, Genomics & Mic...

View all digital editions



Jan 21 2018 Palm Springs, CA, USA


Jan 24 2018 Cardiff, UK

Arab Health

Jan 29 2018 Dubai International Convention & Exhibition Centre

SLAS 2018

Feb 03 2018 San Diego, CA USA


Feb 05 2018 Dubai, UAE

View all events